<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04911829</url>
  </required_header>
  <id_info>
    <org_study_id>Depression Forefront</org_study_id>
    <nct_id>NCT04911829</nct_id>
  </id_info>
  <brief_title>Dysthymia: Associated Costs, Treatment and Change Process</brief_title>
  <acronym>DFront</acronym>
  <official_title>DepressionForefront: Costs, Treatment and Change Process for Dysthymia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Modum Bad</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Modum Bad</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study evaluates cost and effect of inpatient versus outpatient treatment of dysthymia, as&#xD;
      well as investigates the processes through which psychotherapy works in treating dysthymia.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Inpatient treatment allows a more intensive treatment and allows the patient to be in a&#xD;
      context where it is possible to focus on the processes in therapy with minimal interruption.&#xD;
      Outpatient treatment is much less intensive but allows the treatment process to unfold in the&#xD;
      context where the patient is experiencing the problems that brought them to therapy. It is&#xD;
      not clear which of the contexts will be more effective in alleviating symptoms of dysthymia.&#xD;
      Further, as dysthymia is a very costly disease for society it is of interest to know if the&#xD;
      two treatments are cost-effective, and which one is the most cost effective.&#xD;
&#xD;
      A great paucity on dysthymia research ha left the psychotherapy field without an&#xD;
      understanding of the processes through which dysthymia is changed. This study will&#xD;
      investigate the change process through frequent assessments of common factors, psychological&#xD;
      processes, symptoms, heart rate variability and cognitive attention bias.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 2016</start_date>
  <completion_date type="Anticipated">December 2026</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Depressive symptoms</measure>
    <time_frame>At assessment, start (12 weeks after assessment) and end (24 weeks after assessment) of therapy, and at one-year follow up (76 weeks after assessment).</time_frame>
    <description>Beck depression inventory</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Depressive symptoms</measure>
    <time_frame>Once every week for the 12 weeks of active psychotherapy</time_frame>
    <description>Patient health questionnaire</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Cost of living with dysthymia</measure>
    <time_frame>pre therapy, one-year and 10 years</time_frame>
    <description>cost of living with dysthymia, cost-effectiveness of therapy at one-year and at 10 years. Information will be gathered from various registries and combined to a sum of money.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Emotional psychological processes</measure>
    <time_frame>Once every week for the 12 weeks of active psychotherapy</time_frame>
    <description>weekly measures of central emotional psychological processes (Modum Process Outcome questionnaire, M-poq. Calculated as mean of scores. Range 1-7, lower is better).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>cognitive psychological processes</measure>
    <time_frame>Once every week for the 12 weeks of active psychotherapy</time_frame>
    <description>weekly measures of central cognitive psychological processes (Modum Process Outcome questionnaire, M-poq. Calculated as mean of scores. Range 1-7, lower is better).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>metacognitive psychological processes</measure>
    <time_frame>Once every week for the 12 weeks of active psychotherapy</time_frame>
    <description>weekly measures of central metacognitive psychological processes (Modum Process Outcome questionnaire, M-poq. Calculated as mean of scores. Range 1-7, lower is better).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Common factors-alliance</measure>
    <time_frame>Once every week for the 12 weeks of active psychotherapy</time_frame>
    <description>weekly measures of central common factors (Modum Process Outcome questionnaire, M-poq. Calculated as mean of scores. Range 1-7, higher is better).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Common factors-expectations</measure>
    <time_frame>Once every week for the 12 weeks of active psychotherapy</time_frame>
    <description>weekly measures of central common factors (Modum Process Outcome questionnaire, M-poq. Calculated as mean of scores. Range 1-7, higher is better).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Common factors-credibility</measure>
    <time_frame>Once every week for the 12 weeks of active psychotherapy</time_frame>
    <description>weekly measures of central common factors (Modum Process Outcome questionnaire, M-poq. Calculated as mean of scores. Range 1-7, higher is better).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Common factors-explanation</measure>
    <time_frame>Once every week for the 12 weeks of active psychotherapy</time_frame>
    <description>weekly measures of central common factors (Modum Process Outcome questionnaire, M-poq. Calculated as mean of scores. Range 1-7, higher is better).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>anxiety Symptoms</measure>
    <time_frame>Once every week for the 12 weeks of active psychotherapy</time_frame>
    <description>weekly measures of Generalized Anxiety Disorders 7-item (GAD7)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>resilience</measure>
    <time_frame>Once every week for the 12 weeks of active psychotherapy</time_frame>
    <description>weekly measures of resilience (Modum Process Outcome questionnaire, M-poq. Calculated as mean of scores. Range 1-7, higher is better).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>loneliness</measure>
    <time_frame>Once every week for the 12 weeks of active psychotherapy</time_frame>
    <description>weekly measures of loneliness (Modum Process Outcome questionnaire, M-poq. Calculated as mean of scores. Range 1-7, higher is better).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)</measure>
    <time_frame>Once every week for the 12 weeks of active psychotherapy</time_frame>
    <description>weekly measures of wellbeing. 14 Items scored 1-5 (Total score from 14-70). Higher score is better</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Depression</condition>
  <condition>Cost Benefit Analysis</condition>
  <condition>Psychotherapeutic Processes</condition>
  <arm_group>
    <arm_group_label>Inpatient treatment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>High intensity high dosage inpatient short-term psychodynamic psychotherapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Outpatient treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Low dosage outpatient short-term psychodynamic psychotherapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Psychotherapy</intervention_name>
    <arm_group_label>Inpatient treatment</arm_group_label>
    <arm_group_label>Outpatient treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Inclusion criteria will be liberal and similar to clinical practice criteria at the&#xD;
             treatment site: Persistent depressive disorder as defined by the diagnostic and&#xD;
             statistical manual of mental disorders (DSM5); which includes an International&#xD;
             classification of disorders-10 (ICD-10) diagnosis of depression, dysthymia, recurrent&#xD;
             depression. unsuccessful previous treatments. living within driving distance from the&#xD;
             treatment facilities.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  current suicidal risk, current psychosis, marked emotional instability (i.e. issues&#xD;
             with impulsivity), strong paranoid traits, current problems related to heavy substance&#xD;
             abuse.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>P책l Ulvenes, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Modum Bad</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>P책l Ulvenes, PhD</last_name>
    <phone>32749857</phone>
    <email>pal.ulvenes@modum-bad.no</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Linne Melsom, Cand.Psy</last_name>
    <phone>32749700</phone>
    <email>linne.melsom@modum-bad.no</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Modum Bad</name>
      <address>
        <city>Vikersund</city>
        <state>Buskerud</state>
        <zip>3370</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>P책l G Ulvenes, PhD</last_name>
      <phone>32749857</phone>
      <email>pal.ulvenes@modum-bad.no</email>
    </contact>
    <contact_backup>
      <last_name>Terje Tilden, PhD</last_name>
      <phone>32749800</phone>
      <email>terje.tilden@modum-bad.no</email>
    </contact_backup>
    <investigator>
      <last_name>P책l G Ulvenes, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Asle Hoffart, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bruce E Wampold, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 15, 2017</study_first_submitted>
  <study_first_submitted_qc>May 31, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 3, 2021</study_first_posted>
  <last_update_submitted>May 31, 2021</last_update_submitted>
  <last_update_submitted_qc>May 31, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Dysthymia</keyword>
  <keyword>Persistent depressive disorder</keyword>
  <keyword>Chronic depression</keyword>
  <keyword>Recurrent depression</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Dysthymic Disorder</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

